» Articles » PMID: 23569243

Dengue Structure Differs at the Temperatures of Its Human and Mosquito Hosts

Overview
Specialty Science
Date 2013 Apr 10
PMID 23569243
Citations 115
Authors
Affiliations
Soon will be listed here.
Abstract

We report on a conformational transition of dengue virus when changing the temperature from that present in its mosquito vectors to that of its human host. Using cryoelectron microscopy, we show that although the virus has a smooth surface, a diameter of ∼500 Å, and little exposed membrane at room temperature, the virions have a bumpy appearance with a diameter of ∼550 Å and some exposed membrane at 37 °C. The bumpy structure at 37 °C was found to be similar to the previously predicted structure of an intermediate between the smooth mature and fusogenic forms. As humans have a body temperature of 37 °C, the bumpy form of the virus would be the form present in humans. Thus, optimal dengue virus vaccines should induce antibodies that preferentially recognize epitopes exposed on the bumpy form of the virus.

Citing Articles

Hijacking of plasminogen by dengue virus: The kringle-4 and -5 domains of plasminogen binds synergistically to the domain I of envelope protein.

Yuen Y, Sabitha T, Li L, Walvekar V, Ramesh K, Kini R Protein Sci. 2025; 34(2):e70035.

PMID: 39840809 PMC: 11751865. DOI: 10.1002/pro.70035.


Low-temperature culture enhances production of flavivirus virus-like particles in mammalian cells.

Fan Y, Chen J, Chen Y, Hsu W, Chang G, Chiou S Appl Microbiol Biotechnol. 2024; 108(1):242.

PMID: 38416210 PMC: 10902078. DOI: 10.1007/s00253-024-13064-y.


Temperature impacts SARS-CoV-2 spike fusogenicity and evolution.

Dufloo J, Sanjuan R mBio. 2024; 15(4):e0336023.

PMID: 38411986 PMC: 11005339. DOI: 10.1128/mbio.03360-23.


A Prototype-Pathogen Approach for the Development of Flavivirus Countermeasures.

Kuhn R, Barrett A, DeSilva A, Harris E, Kramer L, Montgomery R J Infect Dis. 2023; 228(Suppl 6):S398-S413.

PMID: 37849402 PMC: 10582523. DOI: 10.1093/infdis/jiad193.


The effect of temperature on dengue virus transmission by mosquitoes.

Liu Z, Zhang Q, Li L, He J, Guo J, Wang Z Front Cell Infect Microbiol. 2023; 13:1242173.

PMID: 37808907 PMC: 10552155. DOI: 10.3389/fcimb.2023.1242173.


References
1.
Halstead S . Dengue vaccine development: a 75% solution?. Lancet. 2012; 380(9853):1535-6. DOI: 10.1016/S0140-6736(12)61510-4. View

2.
Tang G, Peng L, Baldwin P, Mann D, Jiang W, Rees I . EMAN2: an extensible image processing suite for electron microscopy. J Struct Biol. 2006; 157(1):38-46. DOI: 10.1016/j.jsb.2006.05.009. View

3.
Teoh E, Kukkaro P, Teo E, Lim A, Tan T, Yip A . The structural basis for serotype-specific neutralization of dengue virus by a human antibody. Sci Transl Med. 2012; 4(139):139ra83. DOI: 10.1126/scitranslmed.3003888. View

4.
Hung J, Hsieh M, Young M, Kao C, King C, Chang W . An external loop region of domain III of dengue virus type 2 envelope protein is involved in serotype-specific binding to mosquito but not mammalian cells. J Virol. 2003; 78(1):378-88. PMC: 303388. DOI: 10.1128/jvi.78.1.378-388.2004. View

5.
Crill W, Roehrig J . Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells. J Virol. 2001; 75(16):7769-73. PMC: 115016. DOI: 10.1128/JVI.75.16.7769-7773.2001. View